Skip to main content

Table 2 Characteristics of Inhibitory and Activatory KIR/HLA mismatches

From: Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)

Characteristics

NO (%)

HLA-C2 absent for donor KIR2DL1

11 (36.6%)

HLA-C1 absent for donor KIR2DL2,3

1 (3.3%)

HLA-Bw4 absent for donor KIR3DL1

5 (16.6%)

HLA-C1 absent for donor KIR2DL3

5 (16.6%)

HLA-C2 present for donor KIR2DS1

4 (13.3%)

HLA-C1 present for donor KIR2DS2

4 (13.3%)

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us